273 related articles for article (PubMed ID: 28607442)
21. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Crimi G; Raineri C; Pica S; Ruffinazzi M; Gianni U; Repetto A; Ferlini M; Marinoni B; Leonardi S; De Servi S; Oltrona Visconti L; De Ferrari GM; Ferrario M
J Cardiovasc Med (Hagerstown); 2018 May; 19(5):240-246. PubMed ID: 29470249
[TBL] [Abstract][Full Text] [Related]
22. Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.
Ghetti G; Bacchi Reggiani ML; Rosetti C; Battistini P; Lanati G; Di Dio MT; Corsini A; Bruno M; Della Riva D; Bruno AG; Compagnone M; Narducci R; Saia F; Rapezzi C; Taglieri N
Medicine (Baltimore); 2018 Sep; 97(37):e12332. PubMed ID: 30212983
[TBL] [Abstract][Full Text] [Related]
23. The impact of preoperative fibrinogen-albumin ratio on mortality in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Xiao L; Jia Y; Wang X; Huang H
Clin Chim Acta; 2019 Jun; 493():8-13. PubMed ID: 30796900
[TBL] [Abstract][Full Text] [Related]
24. Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on 2-year outcomes in patients undergoing percutaneous coronary intervention.
Tang XF; Song Y; Xu JJ; Ma YL; Zhang JH; Yao Y; He C; Wang HH; Jiang P; Jiang L; Liu R; Gao Z; Zhao XY; Qiao SB; Xu B; Yang YJ; Gao RL; Yuan JQ
J Interv Cardiol; 2018 Feb; 31(1):5-14. PubMed ID: 29023996
[TBL] [Abstract][Full Text] [Related]
25. Association of the SYNTAX Score II with cardiac rupture in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Rencuzogullari I; Çağdaş M; Karabağ Y; Karakoyun S; Yesin M; Gürsoy MO; Seyis S; Artaç İ; İliş D; Efe SÇ; Tanboğa İH
Coron Artery Dis; 2018 Mar; 29(2):97-103. PubMed ID: 29028739
[TBL] [Abstract][Full Text] [Related]
26. U-shaped association of central pulse pressure with long-term prognosis after ST-segment elevation myocardial infarction.
Ndrepepa G; Cassese S; Kufner S; Xhepa E; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
Heart Vessels; 2019 Jul; 34(7):1104-1112. PubMed ID: 30671640
[TBL] [Abstract][Full Text] [Related]
27. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Ariza-Solé A; Sánchez-Elvira G; Sánchez-Salado JC; Lorente-Tordera V; Salazar-Mendiguchía J; Sánchez-Prieto R; Romaguera-Torres R; Ferreiro-Gutiérrez JL; Gómez-Hospital JA; Cequier-Fillat A
Thromb Res; 2013; 132(6):652-8. PubMed ID: 24112751
[TBL] [Abstract][Full Text] [Related]
28. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Wang Z; Liu N; Ren L; Lei L; Ye H; Peng J
Arq Bras Cardiol; 2018 Apr; 110(4):333-338. PubMed ID: 29538502
[TBL] [Abstract][Full Text] [Related]
29. Long term prognosis of atrial fibrillation in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Topaz G; Flint N; Steinvil A; Finkelstein A; Banai S; Keren G; Shacham Y; Yankelson L
Int J Cardiol; 2017 Aug; 240():228-233. PubMed ID: 28390742
[TBL] [Abstract][Full Text] [Related]
30. Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention.
Yamashita Y; Shiomi H; Morimoto T; Yaku H; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Abe M; Nagao K; Shizuta S; Ono K; Kimura T;
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28073848
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Factors for In-Hospital and Long-Term Survival in Patients with Acute ST-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.
Hou LL; Gao C; Feng J; Chen ZF; Zhang J; Jiang YJ; Li XX; Wang BN
Tohoku J Exp Med; 2017 May; 242(1):27-35. PubMed ID: 28496014
[TBL] [Abstract][Full Text] [Related]
32. Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).
Kosmidou I; Redfors B; Dordi R; Dizon JM; McAndrew T; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
Am J Cardiol; 2017 May; 119(9):1295-1301. PubMed ID: 28267964
[TBL] [Abstract][Full Text] [Related]
33. Left atrial volume index: Can it provide additional prognostic information in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention?
Cordeiro F; Silva Mateus P; Leão S; Moz M; Trigo J; Ferreira C; Carvalho SS; Ferreira A; Moreira JI
Rev Port Cardiol (Engl Ed); 2018 Oct; 37(10):799-807. PubMed ID: 30318188
[TBL] [Abstract][Full Text] [Related]
34. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C
Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction.
Coelho-Lima J; Georgiopoulos G; Ahmed J; Adil SER; Gaskin D; Bakogiannis C; Sopova K; Ahmed F; Ahmed H; Spray L; Richardson G; Bagnall AJ; Stellos K; Stamatelopoulos K; Spyridopoulos I
Heart; 2021 Dec; 107(23):1881-1888. PubMed ID: 34544804
[TBL] [Abstract][Full Text] [Related]
36. Propensity score matching analysis of the impact of Syntax score and Syntax score II on new onset atrial fibrillation development in patients with ST segment elevation myocardial infarction.
Rencuzogullari I; Çağdaş M; Karakoyun S; Yesin M; Gürsoy MO; Artaç İ; İliş D; Efe SC; Tanboga IH
Ann Noninvasive Electrocardiol; 2018 Mar; 23(2):e12504. PubMed ID: 28975725
[TBL] [Abstract][Full Text] [Related]
37. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
38. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
Khan R; Al-Hawwas M; Hatem R; Azzalini L; Fortier A; Joliecoeur EM; Tanguay JF; Lavoie-L'Allier P; Ly HQ
Catheter Cardiovasc Interv; 2016 Nov; 88(5):740-747. PubMed ID: 26833916
[TBL] [Abstract][Full Text] [Related]
40. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
